Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases

Devkota, HP; Adhikari-Devkota, A; Paudel, KR; Panth, N; Gupta, G; Chellappan, DK; Hansbro, P; Dua, K

Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases

Devkota, HP Adhikari-Devkota, A Paudel, KR Panth, N Gupta, G Chellappan, DK Hansbro, P Dua, K

Permalink

Publisher:: Springer
Publication Type:: Chapter
Citation:: Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases, 2022, pp. 95-106
Issue Date:: 2022-03-24

Closed Access

	Filename	Description	Size
	Phytochemicals and their nanoformulations targeted for pulmonary diseases book chapter.pdf	Published version	242.2 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Devkota, HP
dc.contributor.author	Adhikari-Devkota, A
dc.contributor.author	Paudel, KR
dc.contributor.author	Panth, N
dc.contributor.author	Gupta, G
dc.contributor.author	Chellappan, DK
dc.contributor.author	Hansbro, P
dc.contributor.author	Dua, K
dc.contributor.editor	Chellappan, DK
dc.contributor.editor	Pabreja, K
dc.contributor.editor	Faiyazuddin, M
dc.date.accessioned	2022-03-29T23:49:59Z
dc.date.available	2022-03-29T23:49:59Z
dc.date.issued	2022-03-24
dc.identifier.citation	Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases, 2022, pp. 95-106
dc.identifier.uri	http://hdl.handle.net/10453/155687
dc.description.abstract	Plant-derived natural products, also known as phytochemicals, are one of the most important sources of drug discovery. Due to their wide abundance in nature and structural diversity, various phytochemicals are gaining research interest for the discovery and development of effective therapeutic agents for various diseases, including lung diseases. Bioavailability and metabolism have been the main limiting factors for the effective use of these phytochemicals. In recent years, various novel drug delivery systems, including nanoformulations, have been evaluated for the effective delivery of these phytochemicals. This chapter will cover research related to the potential use of phytochemicals (e.g., polyphenols, alkaloids, steroids) and their nanoformulations in lung diseases.
dc.format.extent	27
dc.language	en
dc.publisher	Springer
dc.relation	Maridulu Budyari Gumal - The Sydney Partnership for Health, Education, Research and Enterprise (SPHERE)N/A
dc.relation.ispartof	Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
dc.relation.isbasedon	10.1007/978-981-16-4392-7_5
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Phytochemicals and their Nanoformulations Targeted for Pulmonary Diseases
dc.type	Chapter
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2022-03-29T23:49:58Z
pubs.place-of-publication	Singapore
pubs.publication-status	Published
dc.location	Singapore

Abstract:

Plant-derived natural products, also known as phytochemicals, are one of the most important sources of drug discovery. Due to their wide abundance in nature and structural diversity, various phytochemicals are gaining research interest for the discovery and development of effective therapeutic agents for various diseases, including lung diseases. Bioavailability and metabolism have been the main limiting factors for the effective use of these phytochemicals. In recent years, various novel drug delivery systems, including nanoformulations, have been evaluated for the effective delivery of these phytochemicals. This chapter will cover research related to the potential use of phytochemicals (e.g., polyphenols, alkaloids, steroids) and their nanoformulations in lung diseases.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/155687